_________
false
C002
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4313
Corporation no:
520039470
Stock Exchange/Market:
NASDAQ CM
1996
380
HaCharoshet st
5
,
Ra'anana
43656
,
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E.mail address:
ir@xtlbio.com
Reported via MAGNA:
10/02/2016
Time of broadcast:
15:36
15:29:44
Company site:
www.xtlbio.com
Reference:
2016-02-026305
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
receiving a patent from the Israeli Patent Office to it's lead drug candidate hCDR1 for the treatment of lupus.
10_02_16_XTLB_6K_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
31/01/2016
Name of the Signatory:
:
Kntor Ronen
,
Position of Signatory in the reporting corporation:
Legal Adviser
,
Name of Employer Company:
.
Abba Hillel Silver Rd
Telephone:
03-6133371
,
Facsimile:
03-6133372
,
E-mail:
rkantor@kantor-law.com
2